A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...
Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to expedite drug development, while continuing to advance its ...
On January 7, 2025, the FDA issued a draft guidance called Considerations for the Use of Artificial Intelligence to Support Regulatory ...
Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform ...
The artificial intelligence community is raving over a new reasoning model that has surprised even Silicon Valley.
Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process more efficient.
The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...
The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...
The Food and Drug Administration (FDA) has recently issued two draft guidance documents aimed at providing recommendations for the use of AI ...
the Food and Drug Administration Monday published its first draft guidance on the use of artificial intelligence in the development of drugs and biological products. The guidance comes as drug ...
Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...